6:30 am Pacira Pharma announces EXPAREL Phase 3 clinical trial in femoral nerve block meets primary efficacy endpoint; sNDA submission expected in second quarter of 2014 with a 10-month PDUFA timeline
View todays social media effects on PCRX
View the latest stocks trending across Twitter. Click to view dashboard
See who Pacira is hiring next, click here to view
